Immucor offers to swap 11 1/8% notes due 2019 for new notes due 2022

By Wendy Van Sickle

Columbus, Ohio, June 19 – Immucor, Inc. launched an offer to exchange its 11 1/8% due 2019 for a new series of 11 1/8% senior notes due 2022, according to a press release.

The company said holders of about 71% of the outstanding principal amount of the existing notes signed on to a support agreement to tender their notes under the offer.

Citigroup Global Markets Inc. has agreed – subject to some conditions, including consummation of the exchange offer – to purchase an amount of new notes equal to the amount of old notes not exchanged in the exchange offer, up to $116 million. The proceeds of those new notes will be used to redeem any unexchanged old notes in full.

The exchange offer will expire at 11:59 p.m., ET on July 17. It is open to only to holders of old notes who have certified to Immucor their status as a qualified institution buyer under Rule 144A or non-U.S. persons under Regulation S.

Global Bondholder Services Corp. (866 470-3800, 212 430-3774 or contact@gbsc-usa.com) is the information agent.

Immucor is a Norcross, Ga.-based provider of automated instrument-reagent systems to the blood transfusion industry.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.